Physician profile
Jonathan Esclovon
NPI 1770019549
$6,193.65
in general payments reported to CMS, 2019-2025
19 companies · $4,382 in 2025
The $4,382 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.37 · 2021: $318 · 2022: $164 · 2023: $1,111 · 2024: $175 · 2025: $4,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,166 · Food and Beverage: $2,439 · Education: $62.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,166.46 |
| Food and Beverage | $2,439.44 |
| Education | $62.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,244.24 | 2021-2025 | Sensia, Advisa Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $843.77 | 2022-2025 | General - Vascular Access, Avvigo Guidance System, Sq-Rx Pulse Generator |
| Abbott Laboratories | $747.43 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Perclose Prostyle |
| Chiesi USA, INC. | $199.26 | 2023 | Kengreal, Cleviprex |
| Nuwellis, INC. | $191.96 | 2023 | Aquadex Smartflow Console |
| Novartis Pharmaceuticals Corporation | $183.94 | 2024-2025 | |
| Shockwave Medical, INC | $156.78 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $116.44 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $100.26 | 2025 | Uptravi, Opsumit, Opsynvi |
| Inari Medical, INC. | $100.22 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $64.15 | 2025 | |
| Amgen INC. | $46.19 | 2024-2025 | Repatha, Repatha |
| Abiomed | $43.37 | 2020 | |
| Kestra Medical Technology Services, INC. | $35.02 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.60 | 2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $27.27 | 2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $26.75 | 2023 | Xarelto |
| Lantheus Medical Imaging, INC. | $21.49 | 2025 | |
| Merck Sharp & Dohme LLC | $17.51 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Esclovon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.